Company attributes
Industry
B2X
CEO
Founder
Legal Name
Sygnature Discovery Limited
Legal classification
Date Incorporated
August 19, 2004
Number of Employees (Ranges)
51 – 200
Email Address
info@sygnaturediscovery.com0
careers@sygnaturediscovery.com
busdev@sygnaturediscovery.com0
Phone Number
+4411594154010
Full Address
The Discovery Building Biocity, Pennyfoot Street, Nottingham, Nottinghamshire, United Kingdom, NG1 1GR0
Incorporation Reference
05210563
Investors
Founded Date
August 19, 2004
Latest Funding Round Date
October 2017
CFO
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
UKSIC Code
72110
Sygnature Discovery is an independent provider of integrated drug discovery resource and expertise. The company's capabilities include medicinal chemistry, in vitro biology, computational chemistry and informatics, DMPK, and protein crystallography (via affiliate company Peak Proteins).
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
